Cargando…
The Promise and the Hype of ‘Personalised Medicine’
Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions, has fallen below expectations because of the challenges of tumour heterogeneity and clonal evolution. In both benign and malignant disease, diseases cause...
Autor principal: | Maughan, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448398/ https://www.ncbi.nlm.nih.gov/pubmed/28517988 http://dx.doi.org/10.1080/20502877.2017.1314886 |
Ejemplares similares
-
Personalised Medicine and the Economy of Biotechnological Promise
por: Sturdy, Steve
Publicado: (2017) -
Personalised nutrition technologies: a new paradigm for dietetic practice and training in a digital transformation era
por: Abrahams, M., et al.
Publicado: (2020) -
Pharmaceutical development and optimization of azithromycin suppository for paediatric use
por: Kauss, Tina, et al.
Publicado: (2013) -
Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear
por: Engleder, Elisabeth, et al.
Publicado: (2014) -
Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
por: Nakase, H., et al.
Publicado: (2017)